Wegovy^® through Hers

Wegovy^® (semaglutide) is a GLP-1 medication approved by the MHRA as a treatment for weight management, when used with a reduced-calorie diet and increased physical activity. It is administered once weekly using a convenient multi-dose injectable pen. In a 68-week clinical trial, participants taking Wegovy^® lost an average of 15% of their body weight; about 1 in 3 achieved 20% weight loss.*

^{*Along with a reduced-calorie diet and increased exercise. Based on a 68-week study, where about 1 in 3 adults with obesity or overweight and weight-related conditions achieved 20% weight loss. Average weight loss achieved was 15%. Wegovy® is a registered trade mark of Novo Nordisk A/S. Hims & Hers Health, Inc. is not affiliated with or endorsed by Novo Nordisk A/S.}

You can see if you’re suitable for Wegovy® through Hers, 100% online via a consultation with a UK-registered clinician. A licensed clinician trained in weight management will review your health history, weight loss goals, and individual needs to determine if Wegovy® through Hims is right for you. If eligible, your treatment will be delivered directly to your door, and you will have access to dynamic tools through the Care Portal.

Wegovy® is MHRA approved for weight management, along with a reduced calorie diet and increased exercise. In a clinical study, Wegovy® reduced the risk of major cardiovascular events (such as heart attack or stroke) in adults with established heart disease who were also obese or overweight.

^{Wegovy® is not indicated to treat hypertension, type 2 diabetes, or dyslipidemia. Along with a reduced calorie diet and increased physical activity. Based on a Wegovy® study of adults with established heart disease and obesity or overweight who also had weight-related medical problems. Adults with diabetes were excluded.}

Wegovy® is a GLP-1 receptor agonist, similar to the body’s naturally-occurring GLP-1 hormone, that helps regulate appetite and reduce calorie intake.^* It binds to receptors in the brain involved in hunger signalling and slows the rate at which food moves through the stomach.^*

^{*Along with a reduced-calorie diet and increased exercise.}

^{**The exact way it works in the brain is not fully understood.}

Wegovy® through Hers treatments start for as low as £149/month for a 12 month plan, if a clinician determines treatment is right for you.

^{Plans are charged upfront. Actual cost may vary depending on the subscription programme.}

Wegovy® is injected once a week and comes in a convenient multi-dose pen. We’ll walk you through how to safely give yourself medication with step-by-step guides and video tutorials in your Care Portal.

Wegovy® has been evaluated and approved by the MHRA for weight management, when combined with a reduced-calorie diet and increased physical activity. See important safety information here.

Wegovy® is licensed for weight management*; Ozempic® is for type 2 diabetes. A clinician will advise what’s appropriate for you.

^{*Along with a reduced calorie diet and increased physical activity. Wegovy® and Ozempic® are registered trade marks of Novo Nordisk A/S. Hims & Hers Health, Inc. is not affiliated with or endorsed by Novo Nordisk A/S.}

Similar to naturally-occurring GLP-1, Wegovy® targets areas of the brain to regulate appetite so you’ll want to eat less.^* In clinical trials, adults taking Wegovy® lost an average of 15% of their body weight; about 1 in 3 achieved 20% weight loss. Individual results may vary^.** When combined with a reduced-calorie diet and increased physical activity, Wegovy® can help support sustained weight loss.^***

^{¹The exact way it works in the brain is not fully understood.}

^{²Along with a reduced-calorie diet and increased exercise. Based on a 68-week study of Wegovy in adults with obesity or overweight and weight-related conditions.}

^{³In a 104-week clinical study of Wegovy® in adults with obesity or overweight and weight-related medical problems, mean weight loss achieved at 2 years was 15.2% vs. 2.6% for placebo. Individual results may vary. Stopping treatment may result in weight regain.}

A clinician will help you start at the right dose and guide you on how to increase it over time. This gradual approach helps your body adjust to the medication while reducing side effects. As your dose increases, your price will remain the same from 0.25 mg to 1 mg. If you and your clinician decide to increase from 1 mg to 1.7 mg or above, you’ll move into a higher pricing tier.^*

^{*Plans are charged upfront. Actual cost may vary depending on the subscription programme.}